Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
Active, not recruiting · NCT04711135 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, digestive system neuroendocrine neoplasm, neoplasm, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-02-12 | NCT04711135 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Advanced Accelerator Applications | 11 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Léon Berard | Lyon | France | 11 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Cincinnati Children's Hospital | Cincinnati | United States | 1 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 45 |
| Maria Sklodowska-Curie National Research Institute of Oncology | Gliwice | Poland | 1 |
| University College Hospital of London | London | United Kingdom | 1 |
| University of Kentucky | Lexington | United States | 98 |